Literature DB >> 21954994

Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.

Alina Sokup1, Barbara Góralczyk, Krzysztof Góralczyk, Danuta Rość.   

Abstract

OBJECTIVE: To investigate whether baseline triglyceride levels are associated with early glucose dysregulation and/or cardiovascular risk in women with a previous history of gestational diabetes.
DESIGN: Prospective postpregnancy cohort study.
SETTING: Polish university hospitals. SAMPLE: Participants included 125 women with previous gestational diabetes and 40 women with normal glucose regulation during pregnancy.
METHODS: All women were studied 2-24 months (mean 12 ± 10 months) after the index pregnancy. Women with previous gestational diabetes were divided into tertiles in accordance with baseline triglyceride levels. MAIN OUTCOME MEASURES: We assessed glucose regulation (oral glucose tolerance test), insulin resistance (homeostasis model assessment), markers of endothelial dysfunction (soluble: intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, tissue plasminogen activator antigen, von Willebrand factor antigen), fibrinolysis (plasminogen activator inhibitor antigen), inflammation (high-sensitivity C-reactive protein) and lipid levels.
RESULTS: Women with previous gestational diabetes (78% normal glucose regulation, 22% impaired glucose tolerance) had a high cardiometabolic risk profile compared with control women (100% normal glucose regulation). Baseline triglycerides >0.83 mmol/l were associated with a higher prevalence of impaired glucose tolerance, higher high-sensitivity C-reactive protein and triglyceride/high-density lipoprotein-cholesterol ratio. Triglycerides >1.22 mmol/l were associated with higher body fat indexes, higher insulin resistance, higher levels of endothelial dysfunction biomarkers, higher plasminogen activator inhibitor antigen and dyslipidemia. Only E-selectin was independently associated with triglyceride levels.
CONCLUSIONS: Baseline triglyceride levels are a cardiovascular risk marker as well as a pathophysiological parameter independently associated with endothelial dysfunction in nondiabetic women with previous gestational diabetes at 2-24 months after an index pregnancy. Normalization of triglycerides should be included in preventive therapy after a pregnancy complicated by gestational diabetes.
© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2012 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21954994     DOI: 10.1111/j.1600-0412.2011.01289.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

Review 1.  Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.

Authors:  Kadri Haller-Kikkatalo; Raivo Uibo
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.

Authors:  Ronée E Harvey; Kirsten E Coffman; Virginia M Miller
Journal:  Womens Health (Lond)       Date:  2015-03

Review 3.  Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra Lassi; Anna Ali; Margaret Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Rev Endocr Metab Disord       Date:  2020-10-27       Impact factor: 6.514

4.  Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Jens Bollerslev; Errol R Norwitz; Pål Aukrust; Tore Henriksen; Thor Ueland
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

5.  Gestational diabetes mellitus worsens the profile of cardiometabolic risk markers and decrease indexes of beta-cell function independently of insulin resistance in nondiabetic women with a parental history of type 2 diabetes.

Authors:  Alina Sokup; Barbara Ruszkowska-Ciastek; Małgorzata Walentowicz-Sadłecka; Marek Grabiec; Danuta Rość
Journal:  J Diabetes Res       Date:  2014-07-06       Impact factor: 4.011

Review 6.  Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update.

Authors:  S Burlina; M G Dalfrà; N C Chilelli; A Lapolla
Journal:  Int J Endocrinol       Date:  2016-11-13       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.